Stockscreener 앱 받기
207.78
1.78%
3.63
시장 영업 전:
207.48
-0.30
-0.14%
Resmed Inc 주식(RMD)의 최신 뉴스
5,006 Shares in ResMed Inc. $RMD Acquired by North Dakota State Investment Board - MarketBeat
ResMed Rises After Partnership With Oura to Expand Sleep Health Education, Care Pathways - Moomoo
Resmed (RMD) Teams Up with Oura to Enhance Sleep Health Educatio - GuruFocus
ResMed stock (US7611521078): sleep apnea specialist in focus after latest quarterly results - AD HOC NEWS
ResMed Inc. stock rises Tuesday, outperforms market - MarketWatch
Resmed Announces Participation in the 46th Annual William Blair Growth Stock Conference - Caledonian Record
ResMed Targets Circadian Data With New Wearable Trial: What Investors Should Watch - TipRanks
Resmed, Oura partner on sleep health education, care - MassDevice
Oura Ring now links sleep changes to Resmed sleep resources - Stock Titan
ResMed Inc stock (US75102W1036): sleep apnea specialist in focus after fresh institutional buying - AD HOC NEWS
ResMed Inc. stock (US7611521078): Earnings beat and dividend lift focus - AD HOC NEWS
Watchman Group, Inc.'s ResMed Inc(RMD) Holding History - GuruFocus
Why this fallen ASX 200 blue chip could be a strong buy - MSN
ResMed Inc. stock rises Monday, outperforms market - MarketWatch
Should you continue to hold Resmed stock in your portfolio? - MSN
Integrated Investment Consultants LLC Invests $1.34 Million in ResMed Inc. $RMD - MarketBeat
Passumpsic Savings Bank Purchases New Stake in ResMed Inc. $RMD - MarketBeat
ResMed Inc. (RMD) Stock Analysis: Exploring a 34% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews
ResMed Inc. stock (US7611521078): dividend in focus after solid Q3 results - AD HOC NEWS
Why are ResMed shares lagging if the business keeps compounding? - MSN
Stephens Investment Management Group LLC Decreases Position in ResMed Inc. $RMD - MarketBeat
ResMed Inc. stock falls Friday, underperforms market - MSN
With Strong Cash Flow, ResMed Stock Poised to Rise? - Trefis
Strong Cash Yield: Is ResMed Stock A Buy? - Trefis
ResMed Inc stock (US75102W1036): Noctrix deal, dividend and shifting sentiment put sleep-therapy spe - AD HOC NEWS
Arbejdsmarkedets Tillaegspension Makes New Investment in ResMed Inc. $RMD - MarketBeat
ResMed Inc stock (AU000000RMD6): Noctrix deal and market cap slide in focus - AD HOC NEWS
Needham reiterates Hold on ResMed stock on Noctrix acquisition By Investing.com - Investing.com South Africa
Needham reiterates Hold on ResMed stock on Noctrix acquisition - Investing.com
ResMed Inc. stock (US7611521078): earnings beat, dividend and softer 2026 share price - AD HOC NEWS
Bank Julius Baer & Co. Ltd Zurich Lowers Stock Position in ResMed Inc. $RMD - MarketBeat
ResMed Inc. $RMD Shares Purchased by AustralianSuper Pty Ltd - MarketBeat
RMD Stock Price, Quote & Chart | RESMED INC (NYSE:RMD) - ChartMill
ResMed Inc stock (US75102W1036): Strong earnings offset by market underperformance - AD HOC NEWS
VIRGINIA RETIREMENT SYSTEMS ET Al Has $23.83 Million Position in ResMed Inc. $RMD - MarketBeat
ResMed stock (US7611521078): Ex-dividend date arrives May 14 amid CEO option exercise - AD HOC NEWS
Swiss Life Asset Management Ltd Cuts Stake in ResMed Inc. $RMD - MarketBeat
ResMed, Inc.: - marketscreener.com
ResMed Inc stock (AU000000RMD6): ex-dividend date approaches May 14 - AD HOC NEWS
ResMed stock (US7611521078): ex-dividend date approaches on May 14 - AD HOC NEWS
ResMed stock (US7611521078): CEO exercises options amid NYSE price drop - AD HOC NEWS
RMD Stock Chart | RESMED INC (NYSE:RMD) - ChartMill
Is ResMed a Better Buy Than Stryker? - Trefis
Should you buy ResMed shares at their 52-week low? - The Motley Fool Australia
ResMed stock hits 52-week low at $198.62 By Investing.com - Investing.com India
A Look at ResMed Inc (RMD) After 3.9% Decline -- GF Value $270.0 - GuruFocus
A Look at ResMed Inc (RMD) After 3.9% Decline -- GF Value $270.01 vs Price $198.76 - GuruFocus
ResMed CEO Farrell Exercises Options and Trims Stake Under 10b5-1 Plan - TipRanks
ResMed Inc. stock falls Monday, underperforms market - MarketWatch
ResMed stock hits 52-week low at $198.62 - Investing.com
ResMed Inc. stock (US7611521078): Recent price dynamics signal trading opportunities - AD HOC NEWS
ResMed (NYSE:RMD) CEO Sells $1,037,229.62 in Stock - MarketBeat
ResMed chairman and CEO Michael Farrell sells $1 million in stock - Investing.com UK
ResMed chairman and CEO Michael Farrell sells $1 million in stock By Investing.com - Investing.com South Africa
Resmed Insider Sold Shares Worth $1,037,233, According to a Recent SEC Filing - marketscreener.com
ResMed (NYSE: RMD) CEO sells 4,991 shares under 10b5-1 plan - Stock Titan
ResMed Inc stock (AU000000RMD6): Sleep apnea and respiratory care leader posts strong growth outlook - AD HOC NEWS
ResMed (NYSE:RMD) Could Be A Buy For Its Upcoming Dividend - Yahoo Finance
ResMed Inc. stock: Earnings beat but shares slip on guidance concerns - AD HOC NEWS
Number of shareholders of ResMed Inc. CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh – LSX:935168 - TradingView
4.66%
0.16%
자본화:
|
볼륨(24시간):